At close: December 13 at 4:00:01 PM EST
After hours: 7:59:41 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
250.0000
--
--
--
Operating Expense
14,406.0000
13,095.0000
15,311.0000
11,737.0000
9,297.0000
Operating Income
-14,406.0000
-12,845.0000
-15,311.0000
-11,737.0000
-9,297.0000
Net Non Operating Interest Income Expense
-13.0000
-15.0000
-13.0000
-3,084.0000
-1,076.0000
Other Income Expense
354.0000
560.0000
1,064.0000
-11,795.0000
51.0000
Pretax Income
-14,065.0000
-12,300.0000
-14,260.0000
-26,616.0000
-10,322.0000
Net Income Common Stockholders
-14,065.0000
-12,316.0000
-14,548.0000
-26,616.0000
-10,322.0000
Average Dilution Earnings
--
--
--
-5,119.0000
--
Diluted NI Available to Com Stockholders
-14,065.0000
-12,316.0000
-14,548.0000
-31,735.0000
-10,322.0000
Basic EPS
-13.26
-27.00
-247.95
-2.14k
-2.79k
Diluted EPS
-13.26
-27.00
-247.95
-2.55k
-2.79k
Basic Average Shares
1,030.6660
456.0140
58.6870
12.4130
3.6990
Diluted Average Shares
1,030.6660
456.0140
58.6870
12.4630
3.6990
Total Operating Income as Reported
-14,631.0000
-13,070.0000
-15,721.0000
-41,854.0000
-9,297.0000
Total Expenses
14,406.0000
13,095.0000
15,311.0000
11,737.0000
9,297.0000
Net Income from Continuing & Discontinued Operation
-14,065.0000
-12,300.0000
-14,260.0000
-26,616.0000
-10,322.0000
Normalized Income
-13,840.0000
-12,075.0000
-12,740.0000
-16,564.0000
-10,360.0000
Interest Expense
13.0000
15.0000
13.0000
2,398.0000
235.0000
Net Interest Income
-13.0000
-15.0000
-13.0000
-3,084.0000
-1,076.0000
EBIT
-14,052.0000
-12,285.0000
-14,247.0000
-24,218.0000
-10,087.0000
EBITDA
-14,049.0000
-12,281.0000
-14,244.0000
-24,216.0000
-10,084.0000
Reconciled Depreciation
3.0000
4.0000
3.0000
2.0000
3.0000
Net Income from Continuing Operation Net Minority Interest
-14,065.0000
-12,300.0000
-14,260.0000
-26,616.0000
-10,322.0000
Total Unusual Items Excluding Goodwill
-225.0000
-225.0000
-1,520.0000
-10,052.0000
38.0000
Total Unusual Items
-225.0000
-225.0000
-1,520.0000
-10,052.0000
38.0000
Normalized EBITDA
-13,824.0000
-12,056.0000
-12,724.0000
-14,164.0000
-10,122.0000
12/31/2020 - 3/30/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
CMRX Chimerix, Inc.
2.9500
+0.34%
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
SLXN Silexion Therapeutics Corp
3.5200
+5.39%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
DBVT DBV Technologies S.A.
3.5700
-7.03%
CDT Conduit Pharmaceuticals Inc.
0.0815
-0.61%